Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Western Europe

The Western Europe Pharma & Healthcare Insight service provides analysis, forecasts and company profiles on a country-by-country basis, covering the key trends impacting pharma and healthcare markets across Western Europe. The service includes access to the very latest analysis plus a searchable archive of articles and data.

To gain FREE trial access for a limited period, click trial.


Latest Stories

Industry

BMI View: The design of drugs - both visual and in terms of their administration - will become an increasingly important facet of the drug development process, as the value of a medicine has to be communicated to both patients and healthcare professionals. Patient expectations will rise as the shift towards taking greater responsibility for personal healthcare plays out, driven... 2010-08-27


France / Industry

BMI's newest core view is that governments in developed states need to work to maintain the countries' long-term attractiveness as sites for clinical trials, especially as the costs... 2010-08-25


Austria / Industry

BMI View: The attractiveness of the Western Europe region to pharmaceutical firms stems from the fact that its countries are key revenue sources for 'big pharma' and particularly for... 2010-08-20


Industry Developments

BMI View: The design of drugs - both visual and in terms of their administration - will become an increasingly important facet of the drug development process, as the value of a medicine... 2010-08-27


France

BMI's newest core view is that governments in developed states need to work to maintain the countries' long-term attractiveness as sites for clinical trials, especially as the costs... 2010-08-25


Austria

BMI View: The attractiveness of the Western Europe region to pharmaceutical firms stems from the fact that its countries are key revenue sources for 'big pharma' and particularly for... 2010-08-20


France

BMI Core View: The development and marketing of therapeutics in combination with diagnostics will become more common. It is increasingly clear that the 'one size fits all' approach... 2010-08-16

Western Europe InsightWestern Europe Channels Western Europe Countries